Last updated on January 2010

Non-Small Cell Lung Cancer


Brief description of study

Non-Small Cell Lung Cancer

Detailed Study Description

First-line treatment for patients with non-squamous non-small cell lung cancer

Patient Inclusion Criteria:

  • Confirmed diagnosis, at least one measurable target lesion, 18+ years of age, life expectancy of >12 weeks

Patient Exclusion Criteria:

  • Small cell or carcinoid lung cancer patients are ineligible, untreated brain metastases, history of active malignancy in the past 3 years

Clinical Study Identifier: TX134709

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dr. Tom Davis

Legacy Pharma Research
Bismarck, ND USA
  Connect »